VRTX

Vertex Pharmaceuticals Inc

• Simply Wall St·1d ago

  Assessing Vertex Pharmaceuticals (VRTX) Valuation After Health Canada Review Progress For Suzetrigine

• Seeking Alpha·2d ago

  Portfolio check: The biggest SA Quant upgrades over the past week

• Reuters·2d ago

  VERTEX PHARMACEUTICALS INC <VRTX.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $542 FROM $525

• PUBT·2d ago

  Nuvalent names Georg Pirmin Meyer chief international officer

• TipRanks·2d ago

  Vertex Pharmaceuticals assumed with a Buy at Truist

• Reuters·2d ago

  U.S. RESEARCH ROUNDUP- Agilent Technologies, Fedex, Synopsys

• Simply Wall St·6d ago

  The Bull Case For Vertex Pharmaceuticals (VRTX) Could Change Following Health Canada’s Review Of Suzetrigine

• Simply Wall St·05/22 21:38

  Health Canada Review Puts Vertex’s Suzetrigine And Valuation In Focus

• NASDAQ·05/22 16:33

  Capital Group Growth ETF Experiences Big Inflow

• Seeking Alpha·05/22 14:27

  BME: Discount Narrows, But A Strong Long-Term Hold Candidate Anyway

• Seeking Alpha·05/21 21:40

  These Are The Upcoming Catalysts For Crispr Therapeutics Stock

• Dow Jones·05/21 17:28

  Vertex Pharmaceuticals Says New Pain Management Drug Is Under Review at Health Canada

• TipRanks·05/21 17:00

  Vertex announces Health Canada acceptance of NDS for suzetrigine

• Reuters·05/21 16:57

  VERTEX ANNOUNCES NEW DRUG SUBMISSION FOR SUZETRIGINE HAS BEEN ACCEPTED FOR REVIEW BY HEALTH CANADA FOR THE TREATMENT OF MODERATE-TO-SEVERE ACUTE PAIN IN ADULTS

• Simply Wall St·05/21 10:31

  Assessing Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Weakness